We previously discovered in vivo synergistic anti-leukemia activity of venetoclax and S63845, as each drug causes marked compensatory upregulation of MCL1 and BCL2 protein levels when used as single agent in zebrafish [41]. The gene discussed is MCL1; the disease is leukemia.